Immatics NV (IMTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.63 -0.08 (-1.70%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.60 -0.03 (-0.65%) 17:39 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | IMTX | CSTL | NAGE | ||
| Company | Immatics NV | Castle Biosciences Inc | Niagen Bioscience Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.68 | 20.01 | 7.33 | ||
| High | 4.98 | 20.09 | 7.33 | ||
| Low | 4.55 | 19.58 | 6.76 | ||
| Last | 4.63 | 19.94 | 6.77 | ||
| Change | -0.08 | -0.16 | -0.62 | ||
| % Change | -1.70% | -0.80% | -8.39% | ||
| Volume | 574,400 | 203,400 | 688,400 | ||
| 20-Day Average Volume | 692,570 | 444,975 | 1,719,755 | ||
| Previous Close | 4.71 | 20.10 | 7.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.73 | 20.27 | 7.50 | ||
| 20-Day Raw Stochastic | 36.31% | 31.96% | 38.44% | ||
| 20-Day Relative Strength | 43.33% | 37.20% | 48.88% | ||
| Weighted Alpha | -62.92 | -19.47 | +10.22 | ||
| Today's Opinion | 88% Sell | 88% Sell | 88% Buy | ||
| Previous Opinion | 88% Sell | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 56% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.40% since 03/21/25 | -2.83% since 03/21/25 | -12.65% since 03/21/25 | ||
| Low | 4.46 on 03/26/25 | 19.58 on 03/28/25 | 6.76 on 03/28/25 | ||
| High | 5.21 on 03/27/25 | 21.14 on 03/24/25 | 8.00 on 03/24/25 | ||
| 1-Month | |||||
| %Chg | +5.71% since 02/28/25 | -8.03% since 02/28/25 | +20.04% since 02/28/25 | ||
| Low | 4.06 on 03/04/25 | 18.70 on 03/10/25 | 5.26 on 03/04/25 | ||
| High | 5.63 on 03/20/25 | 22.58 on 03/04/25 | 9.18 on 03/05/25 | ||
| 3-Month | |||||
| %Chg | -35.06% since 12/27/24 | -25.68% since 12/27/24 | +22.64% since 12/27/24 | ||
| Low | 4.06 on 03/04/25 | 18.70 on 03/10/25 | 5.16 on 01/07/25 | ||
| High | 7.69 on 01/02/25 | 32.74 on 01/08/25 | 9.18 on 03/05/25 | ||
| 6-Month | |||||
| %Chg | -60.53% since 09/27/24 | -28.43% since 09/27/24 | +78.16% since 09/27/24 | ||
| Low | 4.06 on 03/04/25 | 18.70 on 03/10/25 | 3.18 on 10/10/24 | ||
| High | 11.83 on 09/30/24 | 35.84 on 11/05/24 | 9.18 on 03/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 552,618 | 558,459 | 526,368 | ||
| Shares Outstanding, K | 119,356 | 28,007 | 77,750 | ||
| Annual Sales | 58,440,000 | 332,070,000 | 99,600,000 | ||
| Annual Net Income | -104,980,000 | 18,250,000 | 8,550,000 | ||
| Last Quarter Sales | 55,590,000 | 86,310,000 | 29,130,000 | ||
| Last Quarter Net Income | -9,420,000 | 9,590,000 | 7,180,000 | ||
| 60-Month Beta | 0.83 | 0.98 | 2.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/18/24 | 0.32 on 02/27/25 | 0.03 on 03/04/25 | ||
| Latest Earnings Date | 05/13/25 | 05/01/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.64 | 32.42 | 184.75 | ||